Stay Updated

Get a weekly digest of the latest psychedelic research, new studies, and platform updates delivered to your inbox.

No spam, ever. Unsubscribe anytime.

Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study

ObservationalManualMay 17, 2016DOI

Abstract

Medical Research Council.

Authors (14)

LeadImperial College London

Imperial College London

University College London

Barts Health NHS Trust

King's College London

Beckley Foundation

South London and Maudsley NHS Foundation Trust

University College London

MeSH Terms

PsilocybinDosingTreatment-resistant depressionAdverse effectMedicineDepression (economics)Randomized controlled trialAnxietyPsychiatryHallucinogenPsychologyInternal medicinePsychedelics and Drug StudiesChemical synthesis and alkaloidsNeurotransmitter Receptor Influence on Behavior

Metadata

Study TypeObservational

SourceManual

Publication DateMay 17, 2016

Citations1492

Impact Score

62/ 100

Moderate relevance

External Links

DView DOI

X LinkedIn Email